Top

Published in:

Open Access 01-09-2015 | Original Article

Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer

Authors: F. G. J. Kallenberg, J. E. G. IJspeert, P. M. M. Bossuyt, C. M. Aalfs, E. Dekker

Published in: Familial Cancer | Issue 3/2015

Abstract

We developed and validated an online questionnaire to document familial cancer history, in order to facilitate the detection of persons with a familial or hereditary colorectal cancer (CRC) risk. The development of the self-administered online questionnaire for the assessment of familial and hereditary CRC risk was based on nationwide criteria for referral to genetic specialists due to a Lynch syndrome suspicion, as well as existing criteria for surveillance colonoscopies because of an increased risk of familial CRC. The questionnaire was validated at a private colonoscopy center. Patients scheduled for colonoscopy were enrolled (n = 150). Performance of the questionnaire was assessed by comparing referrals based on questionnaire data against referral decisions based on full pedigree data. In a second validation phase, referrals based on questionnaire data were compared with referrals based on data collected in a telephone interview. We also calculated inter-observer agreement in referral decisions. In the first validation phase, the questionnaire had a sensitivity of 90 % (95 % CI 55–98 %) at a specificity of 98 % (95 % CI 87–100 %) in identifying persons qualifying for referral. In the second validation phase, sensitivity was 100 % (95 % CI 63–100) at a specificity of 97 % (95 % CI 91–99 %). In both validation phases an inter-observer agreement of 100 % in referral decisions was achieved. The online questionnaire has a high sensitivity and specificity in identifying persons qualifying for referral because of suspected Lynch syndrome or familial CRC. Implementation of this tool in colonoscopy clinics can facilitate the detection of patients with hereditary or familial CRC.

The Netherlands Cancer Registry and Statistics 1990–2013; 2013. http://www.cijfersoverkanker.nl/?language=en

Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA 60(5):277–300. doi:10.3322/caac.20073 PubMed

Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765–781. doi:10.1016/j.ejca.2009.12.014 PubMedCrossRef

Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348(10):919–932. doi:10.1056/NEJMra012242 PubMedCrossRef

de Jong AE, Vasen HF (2006) The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands. Neth J Med 64(10):367–370PubMed

Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S (2004) Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2(9):813–819PubMedCrossRef

Hampel H, Frankel WL, Martin E et al (2008) Feasibility of screening for Lynch syndrome among patients with colorectal cancer. Journal Clin Oncol 26(35):5783–5788. doi:10.1200/jco.2008.17.5950 CrossRef

Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int Journal Cancer 64(6):430–433CrossRef

Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76(1):1–18. doi:10.1111/j.1399-0004.2009.01230.x PubMedCentralPubMedCrossRef

10.

Giardiello FM, Allen JI, Axilbund JE et al (2014) Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc 80(2):197–220. doi:10.1016/j.gie.2014.06.006 PubMedCrossRef

11.

Dutch Society For Clinical Genetics (2008) CBO guideline hereditary colorectal cancer 2008. Van den Boogaard, Oisterwijk

12.

American Gastroenterological Associatio (2001) American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology 121(1):195–197CrossRef

13.

Vasen HF, van der Meulen-de Jong AE, de Vos Tot Nederveen Cappel WH, Oliveira J, Group EGW (2009) Familial colorectal cancer risk: ESMO clinical recommendations. Ann Oncol 20(Suppl 4):51–53. doi:10.1093/annonc/mdp127 PubMed

14.

Dove-Edwin I, Sasieni P, Adams J, Thomas HJ (2005) Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 331(7524):1047. doi:10.1136/bmj.38606.794560.EB PubMedCentralPubMedCrossRef

15.

Winawer S, Fletcher R, Rex D et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale: update based on new evidence. Gastroenterology 124(2):544–560. doi:10.1053/gast.2003.50044 PubMedCrossRef

16.

de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P et al (2003) Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 52(12):1752–1755PubMedCentralPubMedCrossRef

17.

Dekker N, Hermens RP, Nagengast FM, van Zelst-Stams WA, Hoogerbrugge N (2013) Familial colorectal cancer risk assessment needs improvement for more effective cancer prevention in relatives. Colorectal Dis 15(4):e175–e185. doi:10.1111/codi.12117 discussion p.e85PubMedCrossRef

18.

Schroy PC, Barrison AF, Ling BS, Wilson S, Geller AC (2002) Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol 97(4):1031–1036. doi:10.1111/j.1572-0241.2002.05624.x PubMedCrossRef

19.

van Dijk DA, Oostindier MJ, Kloosterman-Boele WM, Krijnen P, Vasen HF, Hereditary Tumor Study Group of the Comprehensive Cancer Centre West (2007) Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data. Fam Cancer 6(1):131–134. doi:10.1007/s10689-006-9114-8 PubMedCentralPubMedCrossRef

20.

Kessels K, de Groot NL, Fidder HH et al (2013) Recording of family history is associated with colorectal cancer stage. Eur J Gastroenterol Hepatol 25(4):482–487. doi:10.1097/MEG.0b013e32835c45a3 PubMed

21.

Metcalfe A, Werrett J, Burgess L, Chapman C, Clifford C (2009) Cancer genetic predisposition: information needs of patients irrespective of risk level. Fam Cancer 8(4):403–412. doi:10.1007/s10689-009-9256-6 PubMedCrossRef

22.

Rubin DT, Gandhi RK, Hetzel JT et al (2009) Do colorectal cancer patients understand that their family is at risk? Dig Dis Sci 54(11):2473–2483. doi:10.1007/s10620-009-0940-z PubMedCrossRef

23.

Staal-Rosier PM, Rabeling-Keus IM, Kruyt M (2009) Inadequate referral for genetic evaluations of patients with colorectal carcinoma. Ned Tijdschr Geneeskd 153(4):124–128PubMed

24.

Wood ME, Kadlubek P, Pham TH et al (2014) Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. J C Oncol 32(8):824–829. doi:10.1200/jco.2013.51.4661 CrossRef

25.

Dekker N, Hermens RP, Mensenkamp AR, van Zelst-Stams WA, Hoogerbrugge N (2014) Easy-to-use online referral test detects most patients with a high familial risk of colorectal cancer. Colorectal Dis 16(1):O26–O34. doi:10.1111/codi.12407 PubMedCrossRef

26.

Pieper C, Kolankowska I, Jockel KH (2012) Does a screening questionnaire for familial and hereditary colorectal cancer risk work in a health insurance population? Eur J Cancer Care 21(6):758–765. doi:10.1111/j.1365-2354.2012.01358.x CrossRef

27.

Emery J, Morris H, Goodchild R et al (2007) The GRAIDS trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer 97(4):486–493. doi:10.1038/sj.bjc.6603897 PubMedCentralPubMedCrossRef

28.

Rubinstein WS, Acheson LS, O’Neill SM et al (2011) Clinical utility of family history for cancer screening and referral in primary care: a report from the family healthware impact trial. Genet Med 13(11):956–965. doi:10.1097/GIM.0b013e3182241d88 PubMedCentralPubMedCrossRef

29.

Emery JD, Reid G, Prevost AT, Ravine D, Walter FM (2014) Development and validation of a family history screening questionnaire in Australian primary care. Ann Fam Med 12(3):241–249. doi:10.1370/afm.1617 PubMedCentralPubMedCrossRef

30.

Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34(5):424–425PubMedCrossRef

31.

Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6):1453–1456PubMedCrossRef

32.

Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268PubMedCentralPubMedCrossRef

33.

Aaronson N, Alonso J, Burnam A et al (2002) Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 11(3):193–205PubMedCrossRef

34.

Fransen MP, Van Schaik TM, Twickler TB, Essink-Bot ML (2011) Applicability of internationally available health literacy measures in the Netherlands. J Health Commun 16(Suppl 3):134–149. doi:10.1080/10810730.2011.604383 PubMedCrossRef

35.

Chew LD, Bradley KA, Boyko EJ (2004) Brief questions to identify patients with inadequate health literacy. Fam Med 36(8):588–594PubMed

36.

World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191–2194. doi:10.1001/jama.2013.281053 CrossRef

37.

Worthley DL, Smith A, Bampton PA, Cole SR, Young GP (2006) Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. Eur J Gastroenterol Hepatol 18(10):1079–1083. doi:10.1097/01.meg.0000231754.35340.fa PubMedCrossRef

38.

Dudley-Brown S, Freivogel M (2009) Hereditary colorectal cancer in the gastroenterology clinic: how common are at-risk patients and how do we find them? Gastroenterol Nurs 32(1):8–16. doi:10.1097/SGA.0b013e3181965d04 PubMedCrossRef

39.

Sweet KM, Bradley TL, Westman JA (2002) Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol 20(2):528–537PubMedCrossRef

40.

Gagnon MP, Desmartis M, Labrecque M et al (2012) Systematic review of factors influencing the adoption of information and communication technologies by healthcare professionals. J Med Syst 36(1):241–277. doi:10.1007/s10916-010-9473-4 PubMedCentralPubMedCrossRef

41.

Murff HJ, Spigel DR, Syngal S (2004) Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 292(12):1480–1489. doi:10.1001/jama.292.12.1480 PubMedCrossRef

42.

Egger MJ, Lukacz ES, Newhouse M, Wang J, Nygaard I (2013) Web versus paper-based completion of the epidemiology of prolapse and incontinence questionnaire. Female Pelvic Med Reconstr Surg 19(1):17–22. doi:10.1097/SPV.0b013e31827bfd93 PubMedCentralPubMedCrossRef

43.

Clayton JA, Eydelman M, Vitale S et al (2013) Web-based versus paper administration of common ophthalmic questionnaires: comparison of subscale scores. Ophthalmology 120(10):2151–2159. doi:10.1016/j.ophtha.2013.03.019 PubMedCrossRef

44.

Acheson LS, Zyzanski SJ, Stange KC, Deptowicz A, Wiesner GL (2006) Validation of a self-administered, computerized tool for collecting and displaying the family history of cancer. Journal Clin Oncol 24(34):5395–5402. doi:10.1200/jco.2006.07.2462 CrossRef

45.

Qureshi N, Bethea J, Modell B et al (2005) Collecting genetic information in primary care: evaluating a new family history tool. Fam Pract 22(6):663–669. doi:10.1093/fampra/cmi073 PubMedCrossRef

Title: Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer
Authors: F. G. J. Kallenberg
J. E. G. IJspeert
P. M. M. Bossuyt
C. M. Aalfs
E. Dekker
Publication date: 01-09-2015
Publisher: Springer Netherlands
Published in: Familial Cancer / Issue 3/2015
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-015-9792-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2015

A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine

Specific Alu elements involved in a significant percentage of copy number variations of the STK11 gene in patients with Peutz–Jeghers syndrome

Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews

The importance of proper bioinformatics analysis and clinical interpretation of tumor genomic profiling: a case study of undifferentiated sarcoma and a constitutional pathogenic BRCA2 mutation and an MLH1 variant of uncertain significance

3′-UTR poly(T/U) repeat of EWSR1 is altered in microsatellite unstable colorectal cancer with nearly perfect sensitivity

The analysis of a large Danish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 11q24

Keynote webinar | Spotlight on antibody–drug conjugates in cancer